No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss-of-function mutation carriers and wild-type subjects

Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss‐of‐function mutation carriers show different rates of sensitizat...

Full description

Saved in:
Bibliographic Details
Published inContact dermatitis Vol. 70; no. 1; pp. 27 - 34
Main Authors Landeck, Lilla, Visser, Maaike, Skudlik, Christoph, Brans, Richard, Kezic, Sanja, John, Swen Malte
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.01.2014
Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0105-1873
1600-0536
1600-0536
DOI10.1111/cod.12109

Cover

Loading…
Abstract Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss‐of‐function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Materials and Methods Four hundred and ninety‐six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Results Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss‐of‐function mutation carriers and wild‐type subjects. For type IV allergens, significantly more FLG loss‐of‐function carriers were found to be sensitized to lanolin and p‐tert‐butylphenol‐formaldehyde resin. Conclusions Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.
AbstractList Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens.BACKGROUNDLoss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens.To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands.OBJECTIVESTo study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands.Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens.MATERIALS AND METHODSFour hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens.Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin.RESULTSOverall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin.Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.CONCLUSIONSProbably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.
Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.
Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.
Summary Background Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Materials and Methods Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Results Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Conclusions Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. [PUBLICATION ABSTRACT]
Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss‐of‐function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Materials and Methods Four hundred and ninety‐six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Results Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss‐of‐function mutation carriers and wild‐type subjects. For type IV allergens, significantly more FLG loss‐of‐function carriers were found to be sensitized to lanolin and p‐tert‐butylphenol‐formaldehyde resin. Conclusions Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.
Author Kezic, Sanja
Landeck, Lilla
Visser, Maaike
Brans, Richard
Skudlik, Christoph
John, Swen Malte
Author_xml – sequence: 1
  givenname: Lilla
  surname: Landeck
  fullname: Landeck, Lilla
  email: llandeck@uos.de
  organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany
– sequence: 2
  givenname: Maaike
  surname: Visser
  fullname: Visser, Maaike
  organization: Coronel Institute of Occupational Health, Academic Medical Centre, University of Amsterdam, 1100 DE, Amsterdam, The Netherlands
– sequence: 3
  givenname: Christoph
  surname: Skudlik
  fullname: Skudlik, Christoph
  organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany
– sequence: 4
  givenname: Richard
  surname: Brans
  fullname: Brans, Richard
  organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany
– sequence: 5
  givenname: Sanja
  surname: Kezic
  fullname: Kezic, Sanja
– sequence: 6
  givenname: Swen Malte
  surname: John
  fullname: John, Swen Malte
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28015237$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23848345$$D View this record in MEDLINE/PubMed
BookMark eNqNkktv1DAUhS1URB-w4A8gSwgJFmn9SGJniQY6jDRqFzxmaTnONfKQ2IOdqAx_hT-LOzMtUiUQd-O7-M6Rrs85RUc-eEDoOSXnNM-FCd05ZZQ0j9AJrQkpSMXrI3RCKKkKKgU_RqcprQmhdcnkE3TMuCwlL6sT9Osq4AiDjt902wPunLUQwRtI2Hkc9ZiXYHECn9zofurRBY_HgE0YhtttuwG8wNp3ePEF676H-DWjuIXxBsDjy-Uc9yGlItjCTt7s5MM07n2MjtFBTDv9jeu7YueXpnYNZkxP0WOr-wTPDu8Z-nz5_tPsQ7G8ni9mb5eFKauyKQxhhnelbVoOmhEuhQHOK0lYI2ytKyg7y1spLWFUGCs6YW1nW9KIqqkoB36GXu99NzF8nyCNanDJQN9rD2FKipYNq-tsR_8DrRtGatmwjL58gK7DFH0-RNGK1UwSQetMvThQUztApzbR5TC26i6hDLw6ADoZ3duovXHpDydJduMic2_2nIn5vyPYe4QSddsSlVuidi3J7MUD1rh9JGPUrv-XIqcE279bq9n1uztFsVe4NMKPe0UumqoFF5VaXc3VSrD56iNfKc5_A2WQ3KQ
CODEN CODEDG
CitedBy_id crossref_primary_10_1111_bjd_14793
crossref_primary_10_1111_cod_12789
crossref_primary_10_1111_1346_8138_16087
crossref_primary_10_1684_ejd_2018_3422
crossref_primary_10_1016_j_jaci_2014_11_017
crossref_primary_10_1111_cod_13268
crossref_primary_10_1016_j_jep_2023_117065
Cites_doi 10.1111/bjd.12035
10.1111/j.1600-0536.2007.01232.x
10.1111/j.1398-9995.2006.01029.x
10.1111/j.1600-0536.2012.02171.x
10.1001/archderm.1976.01630340009002
10.1016/0895-4356(96)00119-9
10.1055/s-0030-1256476
10.1016/j.jaci.2009.06.046
10.1111/bjd.12083
10.1016/j.jaci.2008.02.014
10.1038/sj.jid.5700630
10.1016/j.jaci.2009.03.036
10.2332/allergolint.10-RAI-0270
10.1016/j.jaci.2010.04.038
10.1038/sj.jid.5701190
10.1111/j.1600-0536.2010.01748.x
10.1016/j.jaci.2006.07.026
10.1136/bmj.b2433
10.1046/j.1365-2133.2001.04277.x
10.1111/j.1365-2133.2010.09708.x
10.2310/6620.2008.08022
10.1038/ng.358
10.1016/j.jaci.2006.08.030
10.1001/archderm.1989.01670150056006
10.2340/00015555-0383
10.1016/j.jaci.2008.01.026
10.1016/j.jaci.2008.01.013
10.1056/NEJMra1011040
10.1016/j.jdent.2010.11.001
10.1111/j.1600-0536.1976.tb03043.x
10.1111/j.1600-0536.2010.01815.x
10.1111/j.1365-4632.2010.04754.x
10.1007/978-3-642-03827-3_24
10.1038/sj.jid.5700739
10.1016/j.jaci.2006.05.004
ContentType Journal Article
Copyright 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2015 INIST-CNRS
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright_xml – notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2015 INIST-CNRS
– notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.1111/cod.12109
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0536
EndPage 34
ExternalDocumentID 3310043401
23848345
28015237
10_1111_cod_12109
COD12109
ark_67375_WNG_W72GWS3W_3
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29F
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABHFT
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F3I
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LMP
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
IQODW
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
ID FETCH-LOGICAL-c4549-c02c3d4f9b3ea20387ce33580297f6a5e4df3b88f0217cf7d7ffdfb09759513e3
IEDL.DBID DR2
ISSN 0105-1873
1600-0536
IngestDate Fri Jul 11 04:14:54 EDT 2025
Fri Jul 11 07:05:51 EDT 2025
Fri Jul 25 19:09:22 EDT 2025
Mon Jul 21 06:04:53 EDT 2025
Wed Apr 02 07:25:26 EDT 2025
Tue Jul 01 03:41:39 EDT 2025
Thu Apr 24 22:58:55 EDT 2025
Wed Jan 22 17:10:54 EST 2025
Wed Oct 30 09:54:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Immunopathology
Allergy
Skin disease
Prick test
Patch test
allergens
filaggrin gene
Contact dermatitis
Gene
loss-of-function mutations
Sensitization
Mutation
Allergen
contact dermatitis
patch test
prick test
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4549-c02c3d4f9b3ea20387ce33580297f6a5e4df3b88f0217cf7d7ffdfb09759513e3
Notes istex:B8F2718F3671F1A273752FDF806833AE662CE019
ark:/67375/WNG-W72GWS3W-3
ArticleID:COD12109
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 23848345
PQID 1526280716
PQPubID 105341
PageCount 8
ParticipantIDs proquest_miscellaneous_1492660291
proquest_miscellaneous_1469206892
proquest_journals_1526280716
pubmed_primary_23848345
pascalfrancis_primary_28015237
crossref_primary_10_1111_cod_12109
crossref_citationtrail_10_1111_cod_12109
wiley_primary_10_1111_cod_12109_COD12109
istex_primary_ark_67375_WNG_W72GWS3W_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01
January 2014
2014-01-00
2014
2014-Jan
20140101
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: Malden
PublicationTitle Contact dermatitis
PublicationTitleAlternate Contact Dermatitis
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
– name: Wiley Subscription Services, Inc
References Fallon P G, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009: 41: 602-608.
Novak N, Baurecht H, Schäfer T et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008: 128: 1430-1435.
Marenholz I, Nickel R, Rüschendorf F et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006: 118: 866-871.
Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown S J, Cordell H J, Irvine A D, Weidinger S. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009: 123: 1361-1370.
Thyssen J P, Carlsen B C, Menné T. Nickel sensitization, hand eczema, and loss-of-function mutations in the filaggrin gene. Dermatitis 2008: 19: 303-307.
Ruëff F, Bergmann K C, Brockow K et al. Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology. Pneumologie 2011: 65: 484-495.
Wakelin S H, Smith H, White I R, Rycroft R J, McFadden J P. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001: 145: 28-31.
van den Oord R A, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009: 339: b2433.
Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989: 125: 366-368.
Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011: 60: 1-9.
Foussereau J, Cavelier C, Selig D. Occupational eczema from para-tertiary-butylphenol formaldehyde resins: a review of the sensitizing resins. Contact Dermatitis 1976: 2: 254-258.
Henderson J, Northstone K, Lee S P et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008: 121: 872-877.
Carlsen B C, Andersen K E, Menné T, Johansen J D. Patients with multiple contact allergies: a review. Contact Dermatitis 2008: 58: 1-8.
Ying S, Meng Q, Corrigan C J, Lee T H. Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 2006: 118: 1386-1388.
Ekelund E, Liedén A, Link J, Lee S P, D'Amato M, Palmer C N, Kockum I, Bradley M. Loss-of-function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families. Acta Derm Venereol 2008: 88: 15-19.
Rogge J L, Hanifin J M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976: 112: 1391-1396.
Carlsen B C, Meldgaard M, Hamann D et al. Latex allergy and filaggrin null mutations. J Dent 2011: 39: 128-132.
Thyssen J P, Johansen J D, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010: 162: 1278-1285.
Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007: 127: 724-726.
Morar N, Cookson W O, Harper J I, Moffatt M F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007: 127: 1667-1672.
Irvine A D, McLean W H, Leung D Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011: 365: 1315-1327.
Heine G, Schnuch A, Uter W, Worm M, Information Network of Departments of Dermatology (IVDK), German Contact Dermatitis Research Group (DKG). Type-IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006: 61: 611-616.
Ross-Hansen K, Menné T, Johansen J D et al. Nickel reactivity and filaggrin null mutations - evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis 2011: 64: 24-31.
Brown S J, Relton C L, Liao H et al. Filaggrin null mutations and childhood AE: a population-based case-control study. J Allergy Clin Immunol 2008: 121: 940-946.
Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006: 118: 214-219.
Diepgen T L, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49: 1031-1038.
Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol 2011: 50: 806-810.
Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, AE, hay fever, and asthma in children. J Allergy Clin Immunol 2008: 121: 1203-1209.
Visser M J, Landeck L, Campbell L E, McLean W H, Weidinger S, Calkoen F, John S M, Kezic S. Impact of loss-of-function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis. Br J Dermatol 2013: 168: 326-332.
Landeck L, Visser M, Kezic S, John S M. Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis 2013: 68: 149-155.
O'Regan G M, Kemperman P M, Sandilands A et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010: 126: 574-580.
Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John S M. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol 2012: 167: 1302-1309.
Scharschmidt T C, Man M Q, Hatano Y et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009: 124: 496-506.
Carlsen B C, Johansen J D, Menné T, Meldgaard M, Szecsi P B, Stender S, Thyssen J P. Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010: 63: 89-95.
2001; 145
2009; 41
2012; 167
2007; 127
2011
2013; 68
2011; 60
2010; 126
2008; 19
2008; 58
1976; 2
2013; 168
2008; 128
2010; 162
2011; 39
2009; 339
2006; 118
2008; 121
2010; 63
1976; 112
2006; 61
1989; 125
2011; 50
2011; 64
2009; 123
2009; 124
2011; 65
2008; 88
1996; 49
2011; 365
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
Thyssen J P (e_1_2_7_36_1) 2008; 19
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
Rogge J L (e_1_2_7_27_1) 1976; 112
References_xml – reference: Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989: 125: 366-368.
– reference: Novak N, Baurecht H, Schäfer T et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008: 128: 1430-1435.
– reference: Marenholz I, Nickel R, Rüschendorf F et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006: 118: 866-871.
– reference: O'Regan G M, Kemperman P M, Sandilands A et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010: 126: 574-580.
– reference: Henderson J, Northstone K, Lee S P et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008: 121: 872-877.
– reference: Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007: 127: 724-726.
– reference: Rogge J L, Hanifin J M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976: 112: 1391-1396.
– reference: Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John S M. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol 2012: 167: 1302-1309.
– reference: Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006: 118: 214-219.
– reference: Brown S J, Relton C L, Liao H et al. Filaggrin null mutations and childhood AE: a population-based case-control study. J Allergy Clin Immunol 2008: 121: 940-946.
– reference: Carlsen B C, Meldgaard M, Hamann D et al. Latex allergy and filaggrin null mutations. J Dent 2011: 39: 128-132.
– reference: Ying S, Meng Q, Corrigan C J, Lee T H. Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 2006: 118: 1386-1388.
– reference: Ruëff F, Bergmann K C, Brockow K et al. Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology. Pneumologie 2011: 65: 484-495.
– reference: Foussereau J, Cavelier C, Selig D. Occupational eczema from para-tertiary-butylphenol formaldehyde resins: a review of the sensitizing resins. Contact Dermatitis 1976: 2: 254-258.
– reference: van den Oord R A, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009: 339: b2433.
– reference: Carlsen B C, Johansen J D, Menné T, Meldgaard M, Szecsi P B, Stender S, Thyssen J P. Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010: 63: 89-95.
– reference: Irvine A D, McLean W H, Leung D Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011: 365: 1315-1327.
– reference: Wakelin S H, Smith H, White I R, Rycroft R J, McFadden J P. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001: 145: 28-31.
– reference: Thyssen J P, Johansen J D, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010: 162: 1278-1285.
– reference: Landeck L, Visser M, Kezic S, John S M. Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis 2013: 68: 149-155.
– reference: Visser M J, Landeck L, Campbell L E, McLean W H, Weidinger S, Calkoen F, John S M, Kezic S. Impact of loss-of-function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis. Br J Dermatol 2013: 168: 326-332.
– reference: Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol 2011: 50: 806-810.
– reference: Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown S J, Cordell H J, Irvine A D, Weidinger S. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009: 123: 1361-1370.
– reference: Carlsen B C, Andersen K E, Menné T, Johansen J D. Patients with multiple contact allergies: a review. Contact Dermatitis 2008: 58: 1-8.
– reference: Morar N, Cookson W O, Harper J I, Moffatt M F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007: 127: 1667-1672.
– reference: Diepgen T L, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49: 1031-1038.
– reference: Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011: 60: 1-9.
– reference: Scharschmidt T C, Man M Q, Hatano Y et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009: 124: 496-506.
– reference: Fallon P G, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009: 41: 602-608.
– reference: Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, AE, hay fever, and asthma in children. J Allergy Clin Immunol 2008: 121: 1203-1209.
– reference: Heine G, Schnuch A, Uter W, Worm M, Information Network of Departments of Dermatology (IVDK), German Contact Dermatitis Research Group (DKG). Type-IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006: 61: 611-616.
– reference: Ross-Hansen K, Menné T, Johansen J D et al. Nickel reactivity and filaggrin null mutations - evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis 2011: 64: 24-31.
– reference: Ekelund E, Liedén A, Link J, Lee S P, D'Amato M, Palmer C N, Kockum I, Bradley M. Loss-of-function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families. Acta Derm Venereol 2008: 88: 15-19.
– reference: Thyssen J P, Carlsen B C, Menné T. Nickel sensitization, hand eczema, and loss-of-function mutations in the filaggrin gene. Dermatitis 2008: 19: 303-307.
– volume: 49
  start-page: 1031
  year: 1996
  end-page: 1038
  article-title: Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness
  publication-title: J Clin Epidemiol
– volume: 123
  start-page: 1361
  year: 2009
  end-page: 1370
  article-title: Meta‐analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease
  publication-title: J Allergy Clin Immunol
– volume: 126
  start-page: 574
  year: 2010
  end-page: 580
  article-title: Raman profiles of the stratum corneum define 3 filaggrin genotype‐determined atopic dermatitis endophenotypes
  publication-title: J Allergy Clin Immunol
– volume: 128
  start-page: 1430
  year: 2008
  end-page: 1435
  article-title: Loss‐of‐function mutations in the filaggrin gene and allergic contact sensitization to nickel
  publication-title: J Invest Dermatol
– volume: 127
  start-page: 724
  year: 2007
  end-page: 726
  article-title: Filaggrin mutations strongly predispose to early‐onset and extrinsic atopic dermatitis
  publication-title: J Invest Dermatol
– volume: 39
  start-page: 128
  year: 2011
  end-page: 132
  article-title: Latex allergy and filaggrin null mutations
  publication-title: J Dent
– volume: 168
  start-page: 326
  year: 2013
  end-page: 332
  article-title: Impact of loss‐of‐function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis
  publication-title: Br J Dermatol
– volume: 63
  start-page: 89
  year: 2010
  end-page: 95
  article-title: Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic
  publication-title: Contact Dermatitis
– volume: 124
  start-page: 496
  year: 2009
  end-page: 506
  article-title: Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens
  publication-title: J Allergy Clin Immunol
– volume: 162
  start-page: 1278
  year: 2010
  end-page: 1285
  article-title: The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population
  publication-title: Br J Dermatol
– volume: 145
  start-page: 28
  year: 2001
  end-page: 31
  article-title: A retrospective analysis of contact allergy to lanolin
  publication-title: Br J Dermatol
– volume: 60
  start-page: 1
  year: 2011
  end-page: 9
  article-title: Filaggrin gene defects and the risk of developing allergic disorders
  publication-title: Allergol Int
– volume: 112
  start-page: 1391
  year: 1976
  end-page: 1396
  article-title: Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation
  publication-title: Arch Dermatol
– volume: 19
  start-page: 303
  year: 2008
  end-page: 307
  article-title: Nickel sensitization, hand eczema, and loss‐of‐function mutations in the filaggrin gene
  publication-title: Dermatitis
– volume: 121
  start-page: 1203
  year: 2008
  end-page: 1209
  article-title: Filaggrin mutations, AE, hay fever, and asthma in children
  publication-title: J Allergy Clin Immunol
– volume: 88
  start-page: 15
  year: 2008
  end-page: 19
  article-title: Loss‐of‐function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families
  publication-title: Acta Derm Venereol
– volume: 50
  start-page: 806
  year: 2011
  end-page: 810
  article-title: Contact sensitization pattern in 172 atopic subjects
  publication-title: Int J Dermatol
– volume: 118
  start-page: 866
  year: 2006
  end-page: 871
  article-title: Filaggrin loss‐of‐function mutations predispose to phenotypes involved in the atopic march
  publication-title: J Allergy Clin Immunol
– volume: 68
  start-page: 149
  year: 2013
  end-page: 155
  article-title: Genotype–phenotype associations in filaggrin loss‐of‐function mutation carriers
  publication-title: Contact Dermatitis
– volume: 58
  start-page: 1
  year: 2008
  end-page: 8
  article-title: Patients with multiple contact allergies: a review
  publication-title: Contact Dermatitis
– volume: 365
  start-page: 1315
  year: 2011
  end-page: 1327
  article-title: Filaggrin mutations associated with skin and allergic diseases
  publication-title: N Engl J Med
– volume: 2
  start-page: 254
  year: 1976
  end-page: 258
  article-title: Occupational eczema from para‐tertiary‐butylphenol formaldehyde resins: a review of the sensitizing resins
  publication-title: Contact Dermatitis
– volume: 61
  start-page: 611
  year: 2006
  end-page: 616
  article-title: Type‐IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG)
  publication-title: Allergy
– volume: 41
  start-page: 602
  year: 2009
  end-page: 608
  article-title: A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming
  publication-title: Nat Genet
– volume: 64
  start-page: 24
  year: 2011
  end-page: 31
  article-title: Nickel reactivity and filaggrin null mutations – evaluation of the filaggrin bypass theory in a general population
  publication-title: Contact Dermatitis
– volume: 127
  start-page: 1667
  year: 2007
  end-page: 1672
  article-title: Filaggrin mutations in children with severe atopic dermatitis
  publication-title: J Invest Dermatol
– volume: 121
  start-page: 940
  year: 2008
  end-page: 946
  article-title: Filaggrin null mutations and childhood AE: a population‐based case–control study
  publication-title: J Allergy Clin Immunol
– volume: 118
  start-page: 1386
  year: 2006
  end-page: 1388
  article-title: Lack of filaggrin expression in the human bronchial mucosa
  publication-title: J Allergy Clin Immunol
– volume: 167
  start-page: 1302
  year: 2012
  end-page: 1309
  article-title: Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy
  publication-title: Br J Dermatol
– start-page: 439
  year: 2011
  end-page: 464
– volume: 339
  start-page: b2433
  year: 2009
  article-title: Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta‐analysis
  publication-title: BMJ
– volume: 65
  start-page: 484
  year: 2011
  end-page: 495
  article-title: Skin tests for diagnostics of allergic immediate‐type reactions. Guideline of the German Society for Allergology and Clinical Immunology
  publication-title: Pneumologie
– volume: 118
  start-page: 214
  year: 2006
  end-page: 219
  article-title: Loss‐of‐function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations
  publication-title: J Allergy Clin Immunol
– volume: 121
  start-page: 872
  year: 2008
  end-page: 877
  article-title: The burden of disease associated with filaggrin mutations: a population‐based, longitudinal birth cohort study
  publication-title: J Allergy Clin Immunol
– volume: 125
  start-page: 366
  year: 1989
  end-page: 368
  article-title: A longitudinal study of contact sensitivity in patients with atopic dermatitis
  publication-title: Arch Dermatol
– ident: e_1_2_7_4_1
  doi: 10.1111/bjd.12035
– ident: e_1_2_7_11_1
  doi: 10.1111/j.1600-0536.2007.01232.x
– ident: e_1_2_7_29_1
  doi: 10.1111/j.1398-9995.2006.01029.x
– ident: e_1_2_7_8_1
  doi: 10.1111/j.1600-0536.2012.02171.x
– volume: 112
  start-page: 1391
  year: 1976
  ident: e_1_2_7_27_1
  article-title: Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1976.01630340009002
– ident: e_1_2_7_7_1
  doi: 10.1016/0895-4356(96)00119-9
– ident: e_1_2_7_9_1
  doi: 10.1055/s-0030-1256476
– ident: e_1_2_7_5_1
  doi: 10.1016/j.jaci.2009.06.046
– ident: e_1_2_7_3_1
  doi: 10.1111/bjd.12083
– ident: e_1_2_7_19_1
  doi: 10.1016/j.jaci.2008.02.014
– ident: e_1_2_7_15_1
  doi: 10.1038/sj.jid.5700630
– ident: e_1_2_7_25_1
  doi: 10.1016/j.jaci.2009.03.036
– ident: e_1_2_7_23_1
  doi: 10.2332/allergolint.10-RAI-0270
– ident: e_1_2_7_16_1
  doi: 10.1016/j.jaci.2010.04.038
– ident: e_1_2_7_34_1
  doi: 10.1038/sj.jid.5701190
– ident: e_1_2_7_31_1
  doi: 10.1111/j.1600-0536.2010.01748.x
– ident: e_1_2_7_13_1
  doi: 10.1016/j.jaci.2006.07.026
– ident: e_1_2_7_20_1
  doi: 10.1136/bmj.b2433
– ident: e_1_2_7_32_1
  doi: 10.1046/j.1365-2133.2001.04277.x
– ident: e_1_2_7_17_1
  doi: 10.1111/j.1365-2133.2010.09708.x
– volume: 19
  start-page: 303
  year: 2008
  ident: e_1_2_7_36_1
  article-title: Nickel sensitization, hand eczema, and loss‐of‐function mutations in the filaggrin gene
  publication-title: Dermatitis
  doi: 10.2310/6620.2008.08022
– ident: e_1_2_7_6_1
  doi: 10.1038/ng.358
– ident: e_1_2_7_24_1
  doi: 10.1016/j.jaci.2006.08.030
– ident: e_1_2_7_28_1
  doi: 10.1001/archderm.1989.01670150056006
– ident: e_1_2_7_12_1
  doi: 10.2340/00015555-0383
– ident: e_1_2_7_18_1
  doi: 10.1016/j.jaci.2008.01.026
– ident: e_1_2_7_22_1
  doi: 10.1016/j.jaci.2008.01.013
– ident: e_1_2_7_2_1
  doi: 10.1056/NEJMra1011040
– ident: e_1_2_7_26_1
  doi: 10.1016/j.jdent.2010.11.001
– ident: e_1_2_7_33_1
  doi: 10.1111/j.1600-0536.1976.tb03043.x
– ident: e_1_2_7_35_1
  doi: 10.1111/j.1600-0536.2010.01815.x
– ident: e_1_2_7_30_1
  doi: 10.1111/j.1365-4632.2010.04754.x
– ident: e_1_2_7_10_1
  doi: 10.1007/978-3-642-03827-3_24
– ident: e_1_2_7_21_1
  doi: 10.1038/sj.jid.5700739
– ident: e_1_2_7_14_1
  doi: 10.1016/j.jaci.2006.05.004
SSID ssj0016428
Score 2.0911517
Snippet Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased...
Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of...
Summary Background Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 27
SubjectTerms Adolescent
Adult
Aged
allergens
Allergens - genetics
Allergens - immunology
Allergic diseases
Biological and medical sciences
Cohort Studies
contact dermatitis
Dermatitis, Allergic Contact - diagnosis
Dermatitis, Allergic Contact - genetics
Dermatitis, Allergic Contact - immunology
Dermatitis, Occupational - diagnosis
Dermatitis, Occupational - genetics
Dermatitis, Occupational - immunology
Female
filaggrin gene
Genetic Markers
Genetic Predisposition to Disease
Genotyping Techniques
Hand
Heterozygote
Humans
Immunopathology
Intermediate Filament Proteins - deficiency
Intermediate Filament Proteins - genetics
Logistic Models
loss-of-function mutations
Male
Medical sciences
Middle Aged
Mutation
patch test
prick test
Skin allergic diseases. Stinging insect allergies
Skin Tests
Young Adult
Title No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss-of-function mutation carriers and wild-type subjects
URI https://api.istex.fr/ark:/67375/WNG-W72GWS3W-3/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcod.12109
https://www.ncbi.nlm.nih.gov/pubmed/23848345
https://www.proquest.com/docview/1526280716
https://www.proquest.com/docview/1469206892
https://www.proquest.com/docview/1492660291
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9RAEF9KC-KL1v-xtawi4ktKkk2yCT5J610r9gS1Xh-EsLvZBWkvKbcJlD75EfwKfjU_iTObP3pSRXw5AplssnOzszM7M78h5GmaSBUJaXyWYguzTMcYJFQ-9gfMcpnw0GDt8NEsPTiOX58kJ2vkxVAL0-FDjAduuDKcvsYFLqT9ZZEr0C-IfoXFeyFLETd__90IHRWiXe3SFxFpM-OsRxXCLJ7xyZW9aAPZeoG5kcICe0zX1-Iqw3PVjnUb0eQm-TRMocs_Od1tG7mrLn9Dd_zPOW6SG72BSl92EnWLrOnqNrl21Ifg75Bvs5ou9UIsT7Hoig4NVkDd0M8VReAJS2tDLSbGN32RJ21qCq9e4BX4vfSQiqqkhx8pNnLB6k9L-3wxOnkzpWfArO9fvtYGfnDfdUMs2i5pgCqxxC571o0B0yqByo1qW4mHSvYuOZ68-rB34Pd9HnwVg3vqqyBSrIxNLpkWEcbTlWYYno1yblKR6Lg0TGaZQf9JGV5yY0ojg5wnYB8yze6R9aqu9ANCjQMbEmEmwTQps0DKWCR5AKPyWIqUeeT58I8XqgdBx14cZ8XgDAHLC8dyjzwZSc875I-riJ45sRkpgPuYKseTYj6bFnMeTefv2byAF--syNX4QAQmQhIx7pHtQdCKXo3YAu6kCFcUph55PN4GBYBRHVHpurXou-VRkGZ59DeaHAwx4GfokfudEP_8AJbhgXICrHGi-OfJFntv993Fw38n3SLXwcSMu0OrbbLeLFv9CMy4Ru649foD3TZF7g
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVKK0FfuF8CpRiEEC-pkjhXiRfUshfYXSRo2b5Ulu3YUtVugjZZCfHEJ_AL_BpfwoxzgUUFIV5WkTJx4tmxfWY8PkPI0ziSKhDSuCzGEmapDnGTULlYHzDNZJT4Bs8OT2fx6Ch8fRwdb5AX3VmYhh-iD7jhyLDzNQ5wDEj_MsoVTDBIf5VdIlshAA10vQ7e9eRRPiJrm8CIXJtpwlpeIczj6R9dW422ULGfMDtSVKAg01S2uAh6riNZuxQNrpGTrhNNBsrZ3qqWe-rzb_yO_9vL6-Rqi1Hpy8aobpANXdwkl6ftLvwt8m1W0qVeiOUZnruiXY0VmHHoaUGRe6KipaEV5sbX7TlPWpcU3r3AK3B96ZiKIqfjDxRrueAB0Iq2KWN0MBnSc9DW9y9fSwM_uPTaJharJm-AKrHEQnuVbQP6lYOUbbVaSYwrVbfJ0eDV4f7IbUs9uCoED9VVXqBYHppMMi0C3FJXmuEObZAlJhaRDnPDZJoadKGUSfLEmNxIL0sigIhMsztksygLfY9QY_mGhJ9KQCd56kkZiijzoNUklCJmDnne_eVctTzoWI7jnHf-EKicW5U75Ekv-rEh_7hI6Jm1m14CtI_ZcknE57MhnyfBcP6ezTm8eHfNsPoHAkAJUcASh-x0lsbbmaTicCdGxiI_dsjj_jbMAbixIwpdrip037LAi9Ms-JtMBlgM9Ok75G5jxT8_gKUYU45ANdYW_9xZvv_2wF7c_3fRR-TK6HA64ZPx7M0Dsg2IM2xiWDtks16u9ENAdbXctYP3BxNdSg0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKK1Vc-P8JlGIQQly2SuIkTsQJtex2oV0QULYHJMt2bAm1m1SbREKceARegVfjSZhxfmBRQYjLKlImTjw7Hn-2Z74h5FESKx1KZUcswRJmqYnwkFCPsD5gmqmYBxZzhw9nyf5R9OI4Pl4jT_tcmJYfYthww5Hh_DUO8LPc_jLINfgXZL_KLpCNKAEkgYjozcAdFSCwdvGLSLWZctbRCmEYz_DoymS0gXr9hMGRsgL92LawxXnIcxXIuplofJl86PvQBqCc7DS12tGff6N3_M9OXiGXOoRKn7UmdZWsmeIa2TzszuCvk2-zki7NQi5PMOuK9hVWwN_QjwVF5omKlpZWGBlfd1metC4pvHqBV7DwpVMqi5xO31Os5ILpnxXtAsbo-GBCT0FZ3798LS384MTrmlg0bdQA1XKJZfYq1wZ0Kwcp12rVKNxVqm6Qo_Hzd7v7o67Qw0hHsD4daT_ULI9sppiRIR6oa8PwfDbMuE1kbKLcMpWmFhdQ2vKcW5tb5Wc8BoDIDLtJ1ouyMLcJtY5tSAapAmySp75SkYwzH1rlkZIJ88iT_h8XumNBx2Icp6JfDYHKhVO5Rx4Oomct9cd5Qo-d2QwSoH2MleOxmM8mYs7Dyfwtmwt48faKXQ0PhIAR4pBxj2z1hiY6P1IJuJMgX1GQeOTBcBs8AB7ryMKUTYWLtyz0kzQL_yaTARIDfQYeudUa8c8PYCnuKMegGmeKf-6s2H215y7u_LvofbL5em8sDqazl3fJRYCbUbuBtUXW62Vj7gGkq9W2G7o_AAb6SLw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=No+remarkable+differences+in+rates+of+sensitization+to+common+type+I+and+IV+allergens+between+FLG+loss-of-function+mutation+carriers+and+wild-type+subjects&rft.jtitle=Contact+dermatitis&rft.au=LANDECK%2C+Lilla&rft.au=VISSER%2C+Maaike&rft.au=SKUDLIK%2C+Christoph&rft.au=BRANS%2C+Richard&rft.date=2014&rft.pub=Blackwell&rft.issn=0105-1873&rft.volume=70&rft.issue=1&rft.spage=27&rft.epage=34&rft_id=info:doi/10.1111%2Fcod.12109&rft.externalDBID=n%2Fa&rft.externalDocID=28015237
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-1873&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-1873&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-1873&client=summon